National Institutes of Health OLAO
FederalMD
Posted
Sep 2, 2026
Sep 11, 2026
Combines Synopsis Solicitation- NULISAseq Inflamma
The Department of Health and Human Services, through the National Institutes of Health’s Office of Logistics and Acquisition Operations, posted a non-competitive combined synopsis/solicitation for NULISAseq Inflamma laboratory testing products or services. The requirement covers specialized medical-laboratory testing to support agency research initiatives under solicitation 75N98026Q01133. It is identified as a sole-source acquisition using streamlined commercial procedures—not a grant—and responses are due September 11, 2026.